Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (Neurological Sciences, (2020), 10.1007/s10072-020-04726-6)

Batista, S., Nunes, C. C., Cerqueira, J. J., Silva, A. M., de Sá, J. C., Ferreira, J., … Sousa, L. (2021, February 1). Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (Neurological Sciences, (2020), 10.1007/s10072-020-04726-6). Neurological Sciences. Springer-Verlag Italia s.r.l. https://doi.org/10.1007/s10072-020-04879-4